Hepatocellular carcinoma - Rising incidence, changing therapeutic strategies

Wiener Medizinische Wochenschrift

Volumn 156, Issue 13-14, 2006, Pages 404-409

  Müller, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alcohol instillation; Chemoembolization; Liver transplantation; Radiofrequency ablation; Resection; Systemic treatment

Indexed keywords

ALPHA INTERFERON; ANTIESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEGESTROL; PRAVASTATIN; RAPAMYCIN; SOMATOSTATIN; TAMOXIFEN; VASCULOTROPIN INHIBITOR;

CANCER INHIBITION; CANCER RECURRENCE; CANCER SURGERY; CHEMOEMBOLIZATION; DISEASE CONTROL; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 33746846935     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-006-0316-3     Document Type: Review

References (45)

1. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750
2. Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19: 271-285
3. Marrero JA (2005) Hepatocellular carcinoma. Curr Opin Gastroenterol 21: 308-312
4. Lopez LJ, Marrero JA (2004) Hepatocellular carcinoma. Curr Opin Gastroenterol 20: 248-253
5. Schöniger-Hekele M, Müller Ch, Kutilek M, Oesterreicher Ch, Ferenci P, Gangl A (2001) Hepatocellular carcinoma in Central Europe: prognostic features and survival. GUT 48: 103-109
6. Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22700 men in Taiwan. Lancet 2: 1129-1133
7. Kendler TW, Egner PA, Wang JB, Zhu YR, Lu PX, Chen JG, Qian GS, Kuang SY, Jackson PE, Gange SJ, Jacobson LP, Munoz A, Groopman JD (2004) Gastroenterology 127 (Suppl 1) S310-318
8. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M (2001) Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. GUT 48: 251-259
9. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christiensen E, Pagliaro L, Colombo M, Rodés J (2001) for the EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35: 421-430
10. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38: S136-S149
11. Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B, Moutardier V, Fargers O, Valla D (2001) Assessment of benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35: 254-258
12. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1999) Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334: 693-699
13. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, França A, Brú C, Navasa M, del Ayuso M, Sole M, Real MI, Vilana R, Rimola A, Visa J, Rodés J (1998) Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 27: 1572-1577
14. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Aschner NL, Roberts JP (2001) Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403
15. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP (2002) Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8: 873-883
16. Toda S, Furukawa H (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma. Ann Surg 240: 451-459
17. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH (2004) Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 10: 36-41
18. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 39: 1434-1440
19. The Liver Cancer Study Group of Japan (1994) Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74: 2272-2280
20. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan J-C, Visa J, Bru C, Rodes J (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 111: 1018-1022
21. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35: 519-524
22. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, Vetrone G, Cavallari A (2003) Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 17 (Suppl 2): 119-129
23. Lau WY, Leung TWT, Ho SKW, Chan M, Machin D, Lau J, Chan ATC, Yeo W, Mok TSK, Yu SCH, Leung NWY, Johnson PJ (1999) Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353: 797-801
24. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT (1999) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma prevention study group. N Engl J Med 340: 1046-1047
25. Takayama T, Sekine T, Makuuchi M,Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807
26. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer. Lancet 32: 228-232
27. Ono T, Yamanoi A, El Assal ON, Kohno H, Nagasue N (2001) Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: Metaanalysis of three randomized controlled trials. Cancer 91: 2378-2385
28. Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K (1996) A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87: 206-211
29. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37: 429-442
30. Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A (1997) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 32: 1168-1173
31. Livraghi T, Benedeni V, Lazzaroni S, Meloni F, Torzilli G, Vettori C (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83: 48-57
32. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197: 101-108
33. Ohnishi K, Yoshioka H, Ito S, Fujiwara K (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27: 67-72
34. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210: 655-661
35. Lin SM, Lin J, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127: 1714-1723
36. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11: 914-921
37. Lai CL, Wu PC, Chan GC, Lok AS, Lin HJ (1988) Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 62: 479-483
38. Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, Tsubota A, Nakamura I, Murashima N, Kumada H, Kawanishi M (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29: 1124-1130
39. Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas V, Rodés J, Bruix J (2000) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 31: 54-58
40. Pierce KHC, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, Soo KC (2002) High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 36: 1221-1226
41. CLIP Group (Cancer of the Liver Italian Programme) (1998) Tamoxifen in treatment of hepatocellular carcinoma: a randomized controlled trial. Lancet 352: 17-20
42. Villa E, Ferretti I, Grottola A, Buttafoco P, Grazia Del Buono M, Giannini F, Manno M, Bertani H, Dugani A, Manenti F (2001) Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. Br J Cancer 84: 881-885
43. Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON (1998) Treatment of hepatocellular carcinoma with octreotide: a randomized controlled study. Gut 42: 442-447
44. Yuen MF, Poon R, Lai CL, Fan ST, Lo CM, Wong KW, Wong WM, Wong BCY (2002) A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology 36: 687-691
45. Kawata S, Yamasaki E, Nagase T, Inui Y, Ito N, Matsuda Y, Inada M, Tamura S, Noda S, Imai Y, Matsuzawa Y (2001) Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Br J Cancer 84: 886-891